9/22/2005. Underwriters for medical device company NxStage Medical Inc. set the terms of the company’s pending initial public offering at 5.5 million shares with an estimated price range between $13 and $15 a share.
9/22/2005. Underwriters for medical device company NxStage Medical Inc. set the terms of the company’s pending initial public offering at 5.5 million shares with an estimated price range between $13 and $15 a share.
